Literature DB >> 1990288

Hyperexpression of interleukin-7 is not necessary or sufficient for transformation of a pre-B lymphoid cell line.

J C Young1, M L Gishizky, O N Witte.   

Abstract

Interleukin-7 (IL-7) is a potent stimulator of pre-B-lymphocyte proliferation. Pre-B cells transformed by a variety of oncogenes including those of the ABL protein tyrosine kinase family were screened for endogenous IL-7 mRNA expression by polymerase chain reaction and a sensitive bioassay for secreted IL-7. Some v-abl but none of the BCR/ABL, v-src, v-fms, v-myc, v-ras, or v-raf transformants analyzed contained elevated IL-7 transcripts. None of the cell lines secreted detectable bioactivity. We overexpressed IL-7 via a retroviral vector in an IL-7-dependent pre-B cell line to assess the potential for autocrine growth stimulation and malignant transformation. We achieved dramatic deregulation of IL-7 translational suppression by removing portions of the 5' flanking region. Levels of IL-7 expression much greater than those needed to establish factor-independent growth did not induce colony formation in agar by IL-7-expressing pre-B cell lines, and the majority of these lines were nontumorigenic in syngeneic mice. The same pre-B cell line transformed by v-abl displayed a highly malignant phenotype while containing dramatically lower IL-7 transcript levels. We conclude that endogenous IL-7 expression is not a necessary event in transformation of pre-B cells, nor is it sufficient to explain the malignant phenotype in v-abl-transformed cells. Up regulation of endogenous IL-7 expression in some transformed pre-B cells may be one of several synergistic events which can lead to malignant conversion.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1990288      PMCID: PMC359737          DOI: 10.1128/mcb.11.2.854-863.1991

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  51 in total

1.  Interleukin 7 is a T-cell growth factor.

Authors:  G D Chazen; G M Pereira; G LeGros; S Gillis; E M Shevach
Journal:  Proc Natl Acad Sci U S A       Date:  1989-08       Impact factor: 11.205

2.  Normal B cell precursors responsive to recombinant murine IL-7 and inhibition of IL-7 activity by transforming growth factor-beta.

Authors:  G Lee; A E Namen; S Gillis; L R Ellingsworth; P W Kincade
Journal:  J Immunol       Date:  1989-06-01       Impact factor: 5.422

3.  The BCR-ABL oncogene transforms Rat-1 cells and cooperates with v-myc.

Authors:  T G Lugo; O N Witte
Journal:  Mol Cell Biol       Date:  1989-03       Impact factor: 4.272

4.  Retrovirus-mediated transfer and expression of the interleukin-3 gene in mouse hematopoietic cells result in a myeloproliferative disorder.

Authors:  P M Wong; S W Chung; C E Dunbar; D M Bodine; S Ruscetti; A W Nienhuis
Journal:  Mol Cell Biol       Date:  1989-02       Impact factor: 4.272

5.  Early pre-B-cell transformation induced by the v-fms oncogene in long-term mouse bone marrow cultures.

Authors:  G V Borzillo; C J Sherr
Journal:  Mol Cell Biol       Date:  1989-09       Impact factor: 4.272

6.  Transfection of a factor-dependent cell line with the murine interleukin-3 (IL-3) cDNA results in autonomous growth and tumorigenesis.

Authors:  F R Jirik; S A Burstein; L Treger; J A Sorge
Journal:  Leuk Res       Date:  1987       Impact factor: 3.156

7.  Alternative forms of the BCR-ABL oncogene have quantitatively different potencies for stimulation of immature lymphoid cells.

Authors:  J McLaughlin; E Chianese; O N Witte
Journal:  Mol Cell Biol       Date:  1989-05       Impact factor: 4.272

8.  A lethal myeloproliferative syndrome in mice transplanted with bone marrow cells infected with a retrovirus expressing granulocyte-macrophage colony stimulating factor.

Authors:  G R Johnson; T J Gonda; D Metcalf; I K Hariharan; S Cory
Journal:  EMBO J       Date:  1989-02       Impact factor: 11.598

9.  N-terminal mutations activate the leukemogenic potential of the myristoylated form of c-abl.

Authors:  P Jackson; D Baltimore
Journal:  EMBO J       Date:  1989-02       Impact factor: 11.598

10.  Deletion of an N-terminal regulatory domain of the c-abl tyrosine kinase activates its oncogenic potential.

Authors:  W M Franz; P Berger; J Y Wang
Journal:  EMBO J       Date:  1989-01       Impact factor: 11.598

View more
  9 in total

Review 1.  An analysis of vertebrate mRNA sequences: intimations of translational control.

Authors:  M Kozak
Journal:  J Cell Biol       Date:  1991-11       Impact factor: 10.539

2.  Structural and signaling requirements for BCR-ABL-mediated transformation and inhibition of apoptosis.

Authors:  D Cortez; L Kadlec; A M Pendergast
Journal:  Mol Cell Biol       Date:  1995-10       Impact factor: 4.272

3.  A 41-kilodalton protein is a potential substrate for the p210bcr-abl protein-tyrosine kinase in chronic myelogenous leukemia cells.

Authors:  E Freed; T Hunter
Journal:  Mol Cell Biol       Date:  1992-03       Impact factor: 4.272

4.  Oncogenic activation of c-ABL by mutation within its last exon.

Authors:  A Goga; J McLaughlin; A M Pendergast; K Parmar; A Muller; N Rosenberg; O N Witte
Journal:  Mol Cell Biol       Date:  1993-08       Impact factor: 4.272

5.  Lymphoid cells transformed by Abelson virus require the v-abl protein-tyrosine kinase only during early G1.

Authors:  Y Y Chen; N Rosenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-01       Impact factor: 11.205

6.  SH1 domain autophosphorylation of P210 BCR/ABL is required for transformation but not growth factor independence.

Authors:  A M Pendergast; M L Gishizky; M H Havlik; O N Witte
Journal:  Mol Cell Biol       Date:  1993-03       Impact factor: 4.272

7.  Direct interaction of Jak1 and v-Abl is required for v-Abl-induced activation of STATs and proliferation.

Authors:  N N Danial; J A Losman; T Lu; N Yip; K Krishnan; J Krolewski; S P Goff; J Y Wang; P B Rothman
Journal:  Mol Cell Biol       Date:  1998-11       Impact factor: 4.272

8.  Cutaneous lymphoproliferation and lymphomas in interleukin 7 transgenic mice.

Authors:  B E Rich; J Campos-Torres; R I Tepper; R W Moreadith; P Leder
Journal:  J Exp Med       Date:  1993-02-01       Impact factor: 14.307

9.  Distinctive growth requirements and gene expression patterns distinguish progenitor B cells from pre-B cells.

Authors:  E A Faust; D C Saffran; D Toksoz; D A Williams; O N Witte
Journal:  J Exp Med       Date:  1993-04-01       Impact factor: 14.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.